Top compounds associated with response to SST


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.048 0.3
mRNA tivozanib CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA tivozanib GDSC1000 pan-cancer AAC -0.0057 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC -0.014 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.043 0.1
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.024 0.5
mRNA triptolide CTRPv2 pan-cancer AAC -0.05 0.1
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.042 0.4
Download CSV